A new drug being tested for colorectal cancer has left the doctors wondering if they found out the permanent cure for the dreaded disease. The drug returned a hundred percent success rate in clinical trials.
Dostarlimab, a drug prepared with laboratory produced molecules that act as substitute to antibodies in the human body, left researchers stunned after all the 18 participants were considered remission one year after the drug trial. Doctors conducted all types of examinations-physical exams, PET scans, MRI scans and many other tests. But the researchers were not able to find a trace of cancer in their bodies. Cancer disappeared for all patients in drug trials.
Dr. Luis A. Diaz Jr. of New York’s Memorial Sloan Kettering Cancer Centre said this was the first time in the history of cancer that such a drug gave one hundred percent results.